Volta Medical Appoints Bill Hoffman as Executive Chairman

Volta Medical Appoints Bill Hoffman as Executive Chairman

Volta Medical has appointed Bill Hoffman as Executive Chairman of its Board of Directors, bringing his extensive experience in guiding startups to success.

Volta Medical has appointed Bill Hoffman as the Executive Chairman of its Board of Directors, announced in a press release. Hoffman, who previously served as CEO of Inari Medical, is recognized for leading the company to significant growth and its eventual acquisition by Stryker for $4.9 billion.

Volta Medical, a health technology company based in Marseille, France, focuses on developing AI solutions to assist electrophysiologists in cardiac ablation procedures. Hoffman's appointment comes as the company aims to expand global access to its AI-driven solutions, which have shown improved efficacy outcomes for atrial fibrillation patients.

In addition to Hoffman's appointment, Jerome Kalifa, MD, PhD, has been named Executive Vice Chairman while continuing his role as Chief Medical Officer. This leadership change follows the publication of the TAILORED-AF clinical trial in Nature Medicine, highlighting the effectiveness of Volta's AI-guided procedures.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more